2020 -2023 Director Board Of Directors @ Chinook Therapeutics, Inc.
2021 -2022 Executive Vice President, Head of Research and Development and Chief Medical Officer @
2018 -2021 Chief Medical Officer @
2016 -2018 Vice President, Head of Translational Medicine for Immunology, Inflammation and Infectious Disease @
2015 -2016 Vice President, Clinical Development and Clinical Immunophenotyping, Pfizer @
2014 -2015 Vice President Chief Development Officer Biosimilars Research and Development Unit @
2012 -2014 Senior Director, Biosimilars Research and Development Unit; Group Global Asset Team Leader @
2012 -2015 Juvenile Diabetes Research Foundation ; Board of Directors--NYC Chapter @
2010 -2015 Board of Directors @ PML Consortium
2010 -2014 Assistant Clinical Attending- Department of Nephrology and Transplantation @
2008 -2012 Immunoscience Medical Director; Global Development Medical Affairs @
2003 -2008 Medical Director Islet Cell Transplantation Program @
2003 -2008 Assistant Professor of Nephrology and Transplantation @
Dolca Thomas Education
Joan & Sanford I. Weill Medical College of Cornell University
Internal Medicine, Nephrology and Transplant Fellowship
1997-2003
Joan & Sanford I. Weill Medical College of Cornell University
Doctor of Medicine - MD
1992-1997
Instituto evangelico
Doctor of Medicine - MD
1992-1997
Cornell University
(Sociology)
1988-1992
Dolca Thomas Skills
Board Level
Non-Executive Director
Strategic Planning
Business Strategy
Clinical Trials
Clinical Research
Immunology
Clinical Development
Oncology
Internal Medicine
Medical Education
Medicine
Infectious Diseases
Biotechnology
Drug Development
Pharmaceutical Industry
Transplant
Nephrology
Diabetes
Medical Affairs
Cell
Medical Writing
Cancer
Hematology
Neuroscience
Therapeutic Areas
Endocrinology
Translational Medicine
CTMS
Informatics
Regulatory Affairs
Lifesciences
GCP
CRO
Medical Research
Protocol
Regulatory Submissions
Pharmacovigilance
Rheumatology
Biopharmaceuticals
Neurology
Cardiology
Pharmacology
Biostatistics
Drug Discovery
Molecular Biology
Dermatology
Epidemiology
Clinical Pharmacology
Vaccines
FDA
Hospitals
Translational Research
Health Economics
Sales
Business Development
Microsoft Word
Development
Biosimilars
Strategy
PowerPoint
Inflammation
Dolca Thomas Summary
Dolca Thomas, based in South San Francisco, CA, US, is currently a Chief Executive Officer at Neolaia Bio. Dolca Thomas brings experience from previous roles at UCB, Ventus Therapeutics, First Tracks Biotherapeutics and Biotech CEO Sisterhood. Dolca Thomas holds a 1997 - 2003 Internal Medicine, Nephrology and Transplant Fellowship @ Joan & Sanford I. Weill Medical College of Cornell University. With a robust skill set that includes Board Level, Non-Executive Director, Strategic Planning, Business Strategy, Clinical Trials and more. Dolca Thomas has 4 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.